Back to Clinical Trials
N/ARecruiting

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Sponsored by Boston Scientific Corporation

About this study

The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS System in the treatment of Parkinson's disease. The utilization of Image Guided Programming (IGP), and other commercially available programming features, used as planning tools for the programming of patients with Boston Scientific's Vercise DBS System are also evaluated. Additionally, the utilization of the DBS Illumina 3D feature that may be used for the programming of patients with Boston Scientific's Vercise DBS Systems is also evaluated.

The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS system in the treatment of Parkinson's disease. Subjects' improvement in disease symptoms and overall Quality of life will be assessed during the study following DBS and compared with baseline. Additionally, the utilization of Image Guided Programming (IGP) when used as a planning tool for programming of patients is also evaluated.

Where this study is enrolling (19)

Show all 19 locations
Who can participate

Inclusion criteria

  • ✓Meets criteria established in locally applicable Vercise System Direction for Use
  • ✓At least 18 years old

Exclusion criteria

  • ✕Meets any contraindication in the Vercise System locally applicable Directions for Use
  • ✕Subjects with significant cognitive or psychiatric impairment may be excluded in the evaluation of GXT.

Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.

Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.

Trial data sourced from ClinicalTrials.gov.